Skip to main content
Top
Published in: Familial Cancer 2/2018

01-04-2018 | Short Communication

Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation

Authors: Sunao Uemura, Hiroyuki Matsubayashi, Yoshimi Kiyozumi, Katsuhiko Uesaka, Yusuke Yamamoto, Keiko Sasaki, Masato Abe, Kenichi Urakami, Masatoshi Kusuhara, Ken Yamaguchi

Published in: Familial Cancer | Issue 2/2018

Login to get access

Abstract

A minor fraction of pancreatic ductal adenocarcinoma (PDAC) develops in association with germline mutations of the genes responsible for inherited cancer syndromes. However, the PDAC that has a germline PTEN mutation has not received much attention. Genome-wide whole exome sequencing was performed on germline and somatic DNA from an 82-year-old woman who had developed a solid pancreatic cancer but did not show characteristic findings of PTEN hamartoma tumor syndromes (PHTS). Histology of the resected pancreatic tumor showed unique PDAC findings of primarily dendriform structures and dense fibrous tissue, accompanied by multiple pancreatic intraepithelial neoplasias in the vicinity. The tumor immunohistochemistry revealed a loss of PTEN expression and overexpression of TP53. Exome sequencing revealed a K-ras mutation (p.Gly12Val). Germline exome sequencing revealed a missense mutation of PTEN (p.Arg234Gln), a rare variant with a reported association with cancer development but not with other PHTS phenotypes. To our knowledge, this is the first report of PDAC associated with a germline PTEN mutation, particularly a rare variant (p.Arg234Gln) with cancer risks.
Appendix
Available only for authorised users
Literature
2.
go back to reference Spinelli L, Black FM, Berg JN et al (2015) Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes. J Med Genet 52:128–134CrossRefPubMed Spinelli L, Black FM, Berg JN et al (2015) Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes. J Med Genet 52:128–134CrossRefPubMed
3.
4.
go back to reference Ying H, Elpek KG, Vinjamoori A et al (2011) PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-kappaB-cytokine network. Cancer Discov 1:158–169CrossRefPubMedPubMedCentral Ying H, Elpek KG, Vinjamoori A et al (2011) PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-kappaB-cytokine network. Cancer Discov 1:158–169CrossRefPubMedPubMedCentral
5.
go back to reference Urakami K, Shimoda Y, Ohshima K et al (2016) Next generation sequencing approach for detecting 491 fusion genes from human cancer. Biomed Res 37:51–62CrossRefPubMed Urakami K, Shimoda Y, Ohshima K et al (2016) Next generation sequencing approach for detecting 491 fusion genes from human cancer. Biomed Res 37:51–62CrossRefPubMed
6.
go back to reference Staal FJ, van der Luijt RB, Baert MR et al (2002) A novel germline mutation of PTEN associated with brain tumours of multiple lineages. Br J Cancer 86:1586–1591CrossRefPubMedPubMedCentral Staal FJ, van der Luijt RB, Baert MR et al (2002) A novel germline mutation of PTEN associated with brain tumours of multiple lineages. Br J Cancer 86:1586–1591CrossRefPubMedPubMedCentral
7.
go back to reference Marsh DJ, Dahia PL, Coulon V et al (1998) Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer 21:61–69CrossRefPubMed Marsh DJ, Dahia PL, Coulon V et al (1998) Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer 21:61–69CrossRefPubMed
8.
go back to reference Caserta E, Egriboz O, Wang H et al (2015) Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev 29:1707–1720CrossRefPubMedPubMedCentral Caserta E, Egriboz O, Wang H et al (2015) Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev 29:1707–1720CrossRefPubMedPubMedCentral
9.
go back to reference Smyrk TC, Watson P, Kaul K et al (2001) Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 91:2417–2422CrossRefPubMed Smyrk TC, Watson P, Kaul K et al (2001) Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 91:2417–2422CrossRefPubMed
Metadata
Title
Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation
Authors
Sunao Uemura
Hiroyuki Matsubayashi
Yoshimi Kiyozumi
Katsuhiko Uesaka
Yusuke Yamamoto
Keiko Sasaki
Masato Abe
Kenichi Urakami
Masatoshi Kusuhara
Ken Yamaguchi
Publication date
01-04-2018
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 2/2018
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-017-0025-7

Other articles of this Issue 2/2018

Familial Cancer 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine